> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Discuss Breast Implant Benefit/Risk
- URL: https://www.fdaweb.com/panel-to-discuss-breast-implant-benefit-risk/
- Published: 2019-02-15T12:00:00.000Z
- Updated: 2026-09-15T01:05:06.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5143395

*Federal Register* notice: FDA has announced a 3/25-26 General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee meeting. Panel members are scheduled to discuss benefits and risks of breast implants indicated for breast augmentation and reconstruction concerning the following topics: (**1**) Breast implant associated anaplastic large cell lymphoma; (**2**) systemic symptoms reported in patients receiving breast implants; (**3**) the use of registries for breast implant surveillance; (**4**) magnetic resonance imaging screening for silent rupture of silicone gel filled breast implants; (**5**) the use of surgical mesh in breast procedures such as breast reconstruction and mastopexy; (**6**) the use of real-world data and patient perspectives in regulatory decision making, and (**7**) best practices for informed consent discussions between patients and clinicians. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-02-15/pdf/2019-02380.pdf?ref=fdaweb.com).